Bora CDMO Bora CDMO

X

Find the latest news about Gan & Lee Pharmaceuticals aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Gan & Lee Pharmaceuticals
China Flag
Country
Country
China
Address
Address
No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District, Beijing 101109
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/gan--lee-pharmaceuticals-begins-first-in-human-trial-in-us-for-investigational-drug-gzr18-301500250.html

PRNEWSWIRE
10 Mar 2022

https://www.indianweb2.com/2021/10/gan-lee-pharmaceuticals-concludes-phase.html

INDIANWEB2
16 Oct 2021

https://en.prnasia.com/releases/apac/gan-lee-pharmaceuticals-to-present-data-at-the-57th-annual-european-association-for-the-study-of-diabetes-meeting-332121.shtml

PRNASIA
08 Sep 2021

https://www.prnewswire.com/news-releases/nuevos-datos-sobre-las-insulinas-aspart-gl-asp-lispro-gl-lis-y-glargina-gl-gla--802413956.html

PR NEWSWIRE
02 Jul 2021

https://www.prnewswire.com/news-releases/new-data-on-phase-1-proposed-biosimilar-gan--lee-insulins-aspart-gl-asp-lispro-gl-lis-and-glargine-gl-gla-presented-at-the-american-diabetes-associations-81st-scientific-sessions-301324495.html

PR NEWSWIRE
02 Jul 2021

https://www.prnewswire.com/news-releases/phase-1-drug-candidate-glr2007-developed-by-gan--lee-has-been-granted-orphan-drug-designation-by-the-us-fda-301128483.html#:~:text=Men's%20Interest-,Phase%201%20Drug%20Candidate%20GLR2007%20Developed%20by%20Gan%20%26%20Lee%20has,Designation%20by%20the%20US%20FDA&text=Gan%20%26%20Lee%20Pharmaceuticals%20Co.%2C%20Ltd.&text=The%20FDA's%20Orphan%20Drug%20Designation,in%20the%20U.S%20annually%202.

PRNNEWSWIRE
11 Sep 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY